|1.||Torok, H: 1 article (07/2004)|
|2.||McMichael, A: 1 article (07/2004)|
|3.||Balkrishnan, R: 1 article (07/2004)|
|4.||Kelly, A P: 1 article (07/2004)|
07/01/2004 - "All measures of efficacy showed that FA+HQ+RA significantly (p<0.0001) improved melasma at 4 weeks with further improvement at 8 weeks across all races/ethnicities and Fitzpatrick skin types. "
07/01/2004 - "An open-label, community-based trial was undertaken at 393 centers in the United States, enrolling 1290 patients representing a broad range of races/ethnicities and all Fitzpatrick skin types, to evaluate the efficacy and safety of a new melasma treatment that combines fluocinolone acetonide 0.01%, hydroquinone 4.0%, and tretinoin 0.05% (FA+HQ+RA) in a hydrophilic cream formulation. "
|1.||Tretinoin (Retinoic Acid)
|2.||Fluocinolone Acetonide (Capex)
|3.||hydroquinone (Black and White)